Skip to main content
Log in

The Effectiveness and Safety of Percutaneous Platelet-Rich Plasma and Bone Marrow Aspirate Concentrate for the Treatment of Suspected Discogenic Low Back Pain: a Comprehensive Review

  • Musculoskeletal Rehabilitation (B Schneider, Section Editor)
  • Published:
Current Physical Medicine and Rehabilitation Reports Aims and scope Submit manuscript

A Correction to this article was published on 20 December 2019

This article has been updated

Abstract

Purpose of Review

Comprehensively review the effectiveness and safety of percutaneous, fluoroscopically guided, intradiscal injection of platelet-rich plasma (PRP) and bone marrow aspirate concentrate (BMAC) for the treatment of suspected discogenic low back pain.

Recent Findings

Publications in PubMed up to February 2019 were independently assessed. The literature search yielded three intradiscal PRP studies: one randomized controlled trial and two prospective cohort studies. Five intradiscal BMAC studies were identified. Four of the five prospective cohort studies were completed by the same primary author and results pertained to the same treatment group at different follow-up time points. A single case series of treatment with intradiscal BMAC was identified.

Summary

The evidence for use of percutaneous, fluoroscopy-guided, intradiscal PRP or BMAC for the treatment of suspected discogenic low back pain appears safe, potentially positive, but is limited due to low-quality studies, natural history of discogenic pain, and variable reporting characteristics. Further quality research is needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Change history

  • 20 December 2019

    The original version of this article unfortunately contained a mistake in the authorgroup section. Author Byron Schneider’s family name was incorrectly presented as “Schnieder”.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Murray CJL, Atkinson C, Bhalla K, et al. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA. 2013;310(6):591–608. https://doi.org/10.1001/jama.2013.13805.

    Article  CAS  PubMed  Google Scholar 

  2. United States Bone and Joint Initiative. By the numbers: musculoskeletal back pain: back and neck disorders, injuries, and disk disorders. www.usbji.org. Accessed March 18, 2019.

  3. Schwarzer AC, Wang SC, Bogduk N, McNaught PJ, Laurent R. Prevalence and clinical features of lumbar zygapophysial joint pain: a study in an Australian population with chronic low back pain. Ann Rheum Dis. 1995;54(2):100–6. https://doi.org/10.1136/ard.54.2.100.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Manchikanti L, Boswell MV, Singh V, Pampati V, Damron KS, Beyer CD. Prevalence of facet joint pain in chronic spinal pain of cervical, thoracic, and lumbar regions. BMC Musculoskelet Disord. 2004;5(1):15. https://doi.org/10.1186/1471-2474-5-15.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Schwarzer AC, Aprill CN, Derby R, Fortin J, Kine G, Bogduk N. The prevalence and clinical features of internal disc disruption in patients with chronic low back pain. Spine (Phila Pa 1976). 1995. https://doi.org/10.1097/00007632-199509000-00007.

  6. Maigne JY, Aivaliklis A, Pfefer F. Results of sacroiliac joint double block and value of sacroiliac pain provocation tests in 54 patients with low back pain. Spine. 1996;21:1889–92. https://doi.org/10.1097/00007632-199608150-00012.

    Article  CAS  PubMed  Google Scholar 

  7. Schwarzer AC, Aprill CN, Bogduk N. The sacroiliac joint in chronic low back pain. Spine (Phila Pa 1976). 1995. https://doi.org/10.1097/00007632-199501000-00007.

  8. Hancock MJ, Maher CG, Latimer J, Spindler MF, McAuley JH, Laslett M, et al. Systematic review of tests to identify the disc, SIJ or facet joint as the source of low back pain. Eur Spine J. 2007;16:1539–50. https://doi.org/10.1007/s00586-007-0391-1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. DePalma MJ, Ketchum JM, Saullo T. What is the source of chronic low back pain and does age play a role? Pain Med. 2011;12(2):224–33. https://doi.org/10.1111/j.1526-4637.2010.01045.x.

    Article  PubMed  Google Scholar 

  10. Cooke PM, Lutz GE. Internal disc disruption and axial back pain in the athlete. Phys Med Rehabil Clin N Am. 2000;11:837–65.

    Article  CAS  PubMed  Google Scholar 

  11. Teraguchi M, Yoshimura N, Hashizume H, Muraki S, Yamada H, Oka H, et al. The association of combination of disc degeneration, end plate signal change, and Schmorl node with low back pain in a large population study: the Wakayama Spine Study. Spine J. 2015;15:622–8. https://doi.org/10.1016/j.spinee.2014.11.012.

    Article  PubMed  Google Scholar 

  12. Haschtmann D, Stoyanov JV, Gédet P, Ferguson SJ. Vertebral endplate trauma induces disc cell apoptosis and promotes organ degeneration in vitro. Eur Spine J. 2008;17:289–99. https://doi.org/10.1007/s00586-007-0509-5.

    Article  PubMed  Google Scholar 

  13. Kim SM, Lee SH, Lee BR, Hwang JW. Analysis of the correlation among age, disc morphology, positive discography and prognosis in patients with chronic low back pain. Ann Rehabil Med. 2015;39:340–6. https://doi.org/10.5535/arm.2015.39.3.340.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Bogduk N, Aprill C, Derby R. Lumbar discogenic pain: state-of-the-art review. Pain Med (United States). 2013;14(6):813–36 http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=2013407027.

    Article  Google Scholar 

  15. McCormick ZL, Lehman VT, Plastaras CT, Walega DR, Huddleston P 3rd, Moussallem C, Geske JR, Verdoorn JT, Kennedy DJ, Maus TP, Carr CM. Low-pressure Lumbar Provocation Discography According to Spine Intervention Society/International Association for the Study of Pain Standards Does Not Cause Acceleration of Disc Degeneration in Patients with Symptomatic Low Back Pain: A 7 Year Matched Cohort Study. Spine (Phila Pa 1976). 2019 Jun 27. https://doi.org/10.1097/BRS.0000000000003085.

  16. Wolfer LR, Derby R, Lee JELS. Systematic review of lumbar provocation discography in asymptomatic subjects with a meta-analysis of false-positive rates. Pain Physician. 2008;11(4):513–39.

    PubMed  Google Scholar 

  17. Carragee EJ. Persistent low back pain. N Engl J Med. 2005;352:1891–8. https://doi.org/10.1056/nejmcp042054.

    Article  CAS  PubMed  Google Scholar 

  18. Kuijpers T, Van Middelkoop M, Rubinstein SM, et al. A systematic review on the effectiveness of pharmacological interventions for chronic non-specific low-back pain. Eur Spine J. 2011;20:40–50. https://doi.org/10.1007/s00586-010-1541-4.

    Article  CAS  PubMed  Google Scholar 

  19. Petersen T, Larsen K, Jacobsen S. One-year follow-up comparison of the effectiveness of McKenzie treatment and strengthening training for patients with chronic low back pain: outcome and prognostic factors. Spine (Phila Pa 1976). 2007. https://doi.org/10.1097/BRS.0b013e31815cda4a.

  20. Dreyfuss P, Halbrook B, Pauza K, Joshi A, McLarty J, Bogduk N. Efficacy and validity of radiofrequency neurotomy for chronic lumbar zygapophysial joint pain. Spine (Phila Pa 1976). 2000. https://doi.org/10.1097/00007632-200005150-00012.

  21. Kapural L, Vrooman B, Sarwar S, et al. A randomized, placebo-controlled trial of teransdiscal radiofrequency, biacuplasty for treatment of discogenic lower back pain. Pain Med (United States). 2013. https://doi.org/10.1111/pme.12023.

  22. Carragee EJ, Cheng I. Minimum acceptable outcomes after lumbar spinal fusion. Spine J. 2010;10:313–20. https://doi.org/10.1016/j.spinee.2010.02.001.

    Article  PubMed  Google Scholar 

  23. Brox JI, Reikerås O, Nygaard Ø, et al. Lumbar instrumented fusion compared with cognitive intervention and exercises in patients with chronic back pain after previous surgery for disc herniation: a prospective randomized controlled study. Pain. 2006;122:145–55. https://doi.org/10.1016/j.pain.2006.01.027.

    Article  PubMed  Google Scholar 

  24. Fritzell P, Hägg O, Wessberg P, Nordwall A. 2001 Volvo award winner in clinical studies: lumbar fusion versus nonsurgical treatment for chronic low back pain. A multicenter randomized controlled trial from the Swedish Lumbar Spine Study Group. Spine (Phila Pa 1976). 2001. https://doi.org/10.1097/00007632-200112010-00002.

  25. Brox JI, Nygaard ØP, Holm I, Keller A, Ingebrigtsen T, Reikerås O. Four-year follow-up of surgical versus non-surgical therapy for chronic low back pain. Ann Rheum Dis. 2010;69:1643–8. https://doi.org/10.1136/ard.2009.108902.

    Article  PubMed  Google Scholar 

  26. Shen L, Yuan T, Chen S, Xie X, Zhang C. The temporal effect of platelet-rich plasma on pain and physical function in the treatment of knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials. J Orthop Surg Res. 2017;12:16. https://doi.org/10.1186/s13018-017-0521-3.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Chahla J, Dean CS, Moatshe G, Pascual-Garrido C, Serra Cruz R, LaPrade RF. Concentrated bone marrow aspirate for the treatment of chondral injuries and osteoarthritis of the knee: a systematic review of outcomes. Orthop J Sport Med. 2016;4(1):1–8. https://doi.org/10.1177/2325967115625481.

    Article  Google Scholar 

  28. Damia E, Chicharro D, Lopez S, Cuervo B, Rubio M, Sopena J, et al. Adipose-derived mesenchymal stem cells: are they a good therapeutic strategy for osteoarthritis? Int J Mol Sci. 2018;19. https://doi.org/10.3390/ijms19071926.

  29. Willett NJ, Thote T, Lin ASP, Moran S, Raji Y, Sridaran S, et al. Intra-articular injection of micronized dehydrated human amnion/chorion membrane attenuates osteoarthritis development. Arthritis Res Ther. 2014;16(1):R47. https://doi.org/10.1186/ar4476.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Wang Y, Yu D, Liu Z, Zhou F, Dai J, Wu B, et al. Exosomes from embryonic mesenchymal stem cells alleviate osteoarthritis through balancing synthesis and degradation of cartilage extracellular matrix. Stem Cell Res Ther. 2017;8:189. https://doi.org/10.1186/s13287-017-0632-0.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Kuroki H, Aoyama T, Iijima H, Takahashi M, Isho T. Effectiveness of mesenchymal stem cells for treating patients with knee osteoarthritis: a meta-analysis toward the establishment of effective regenerative rehabilitation. npj Regen Med. 2018. https://doi.org/10.1038/s41536-018-0041-8.

  32. Lai LP, Stitik TP, Foye PM, Georgy JS, Patibanda V, Chen B. Use of platelet-rich plasma in intra-articular knee injections for osteoarthritis: a systematic review. PM R. 2015;7:637–48. https://doi.org/10.1016/j.pmrj.2015.02.003.

    Article  PubMed  Google Scholar 

  33. Freitag J, Bates D, Wickham J, Shah K, Huguenin L, Tenen A, et al. Adipose-derived mesenchymal stem cell therapy in the treatment of knee osteoarthritis: a randomized controlled trial. Regen Med. February 2019;14:213–30. https://doi.org/10.2217/rme-2018-0161.

    Article  CAS  PubMed  Google Scholar 

  34. Shin TH, Kim HS, Kang TW, Lee BC, Lee HY, Kim YJ, et al. Human umbilical cord blood-stem cells direct macrophage polarization and block inflammasome activation to alleviate rheumatoid arthritis. Cell Death Dis. 2016;7. https://doi.org/10.1038/cddis.2016.442.

  35. • Regulatory considerations for human cells, tissues, and cellular and tissue-based products: minimal manipulation and homologous use. https://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/CellularandGeneTherapy/UCM585403.pdf%2D%2D. Accessed February 16, 2019. The Food and Drug Administration (FDA) established regulations regarding the use of human cells and tissues which dictate that human cells and tissues may be used.

  36. Fice MP, Miller JC, Christian R, Hannon CP, Smyth N, Murawski CD, et al. The role of platelet-rich plasma in cartilage pathology: an updated systematic review of the basic science evidence. Arthrosc - J Arthrosc Relat Surg. 2019;35:961–976.e3. https://doi.org/10.1016/j.arthro.2018.10.125.

    Article  Google Scholar 

  37. McCarrel T, Fortier L. Temporal growth factor release from platelet-rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression. J Orthop Res. 2009;27:1033–42. https://doi.org/10.1002/jor.20853.

    Article  CAS  PubMed  Google Scholar 

  38. Huang AH, Motlekar NA, Stein A, Diamond SL, Shore EM, Mauck RL. High-throughput screening for modulators of mesenchymal stem cell chondrogenesis. Ann Biomed Eng. 2008;36:1909–21. https://doi.org/10.1007/s10439-008-9562-4.

    Article  PubMed  Google Scholar 

  39. Indrawattana N, Chen G, Tadokoro M, Shann LH, Ohgushi H, Tateishi T, et al. Growth factor combination for chondrogenic induction from human mesenchymal stem cell. Biochem Biophys Res Commun. 2004;320:914–9. https://doi.org/10.1016/j.bbrc.2004.06.029.

    Article  CAS  PubMed  Google Scholar 

  40. Chen FH, Tuan RS. Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther. 2008;10:223. https://doi.org/10.1186/ar2514.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. • Chu CR, Rodeo S, Bhutani N, Goodrich LR, Huard J, Irrgang J, LaPrade RF, Lattermann C, Lu Y, Mandelbaum B, Mao J, McIntyre L, Mishra A, Muschler GF, Piuzzi NS, Potter H, Spindler K, Tokish JM, Tuan R, Zaslav KMW. Optimizing clinical use of biologics in orthopaedic surgery: consensus recommendations from the 2018 AAOS/NIH U-13 Conference; 2018. Consensus recommendation from the joint 2018 American Academy of Orthopedic Surgery and National Institutes of Health (AAOS/NIH) conference that provides recommended reporting characteristics to help standardize the autologous biologics research.

  42. Higgins JPT, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. https://doi.org/10.1136/bmj.d5928.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Oxford Centre for Evidence-Based Medicine. http://www.cebm.net/index.aspx?o=5653.

  44. McCormick ZL, Vorobeychik Y, Gill JS, et al. Guidelines for composing and assessing a paper on the treatment of pain: a practical application of evidence-based medicine principles to the mint randomized clinical trials. Pain Med. 2018;19(11):2127–37. https://doi.org/10.1093/pm/pny046.

    Article  PubMed  Google Scholar 

  45. Bogduk N, Kennedy DJ, Vorobeychik Y, Engel A. Guidelines for composing and assessing a paper on treatment of pain. Pain Med (United States). 2017. https://doi.org/10.1093/pm/pnx121.

  46. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. 2009;62. https://doi.org/10.1016/j.jclinepi.2009.06.006.

  47. • Tuakli-Wosornu YA, Terry A, Boachie-Adjei K, et al. Lumbar intradiskal platelet-rich plasma (PRP) injections: a prospective, double-blind, randomized controlled study. PM R. 2016;8(1):1–10; quiz 10. https://doi.org/10.1016/j.pmrj.2015.08.010. Single-center, double-blind RCT evaluating the effectiveness of PRP for the treatment of suspected discogenic back pain in 47 adults.

    Article  PubMed  Google Scholar 

  48. Farrar JT, Young JP, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94:149–58. https://doi.org/10.1016/S0304-3959(01)00349-9.

    Article  CAS  PubMed  Google Scholar 

  49. Levi D, Horn S, Tyszko S, Levin J, Hecht-Leavitt C, Walko E. Intradiscal platelet-rich plasma injection for chronic discogenic low back pain: preliminary results from a prospective trial. Pain Med (United States). 2016;17(6):1010–22. https://doi.org/10.1093/pm/pnv053.

    Article  Google Scholar 

  50. Akeda K, Ohishi K, Masuda K, Bae WC, Takegami N, Yamada J, et al. Intradiscal injection of autologous platelet-rich plasma releasate to treat discogenic low back pain: a preliminary clinical trial. Asian Spine J. 2017;11(3):380–9. https://doi.org/10.4184/asj.2017.11.3.380.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Hu X, Wang C, Rui Y. An experimental study on effect of autologous platelet-rich plasma on treatment of early intervertebral disc degeneration. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2012;26(8):977–83.

    CAS  PubMed  Google Scholar 

  52. • Pettine KA, Murphy MB, Suzuki RK, Sand TT. Percutaneous injection of autologous bone marrow concentrate cells significantly reduces lumbar discogenic pain through 12 months. Stem Cells. 2015;33(1):146–56. https://doi.org/10.1002/stem.1845. Prospective cohort study evaluating the effectiveness of fluoroscopically guided intradiscal injection of BMAC for the treatment of suspected discogenic low back pain in 26 patients. This study had the highest percentage of AAOS reporting characteristics at 67%.

    Article  CAS  PubMed  Google Scholar 

  53. Pettine K, Suzuki R, Sand T, Murphy M. Treatment of discogenic back pain with autologous bone marrow concentrate injection with minimum two year follow-up. Int Orthop. 2016;40(1):135–40. https://doi.org/10.1007/s00264-015-2886-4.

    Article  PubMed  Google Scholar 

  54. Pettine KA, Suzuki RK, Sand TT, Murphy MB. Autologous bone marrow concentrate intradiscal injection for the treatment of degenerative disc disease with three-year follow-up. Int Orthop. 2017;41(10):2097–103. https://doi.org/10.1007/s00264-017-3560-9.

    Article  PubMed  Google Scholar 

  55. Pettine MDK, Dordevic M, Hasz MDM. Reducing lumbar discogenic back pain and disability with intradiscal injection of bone marrow concentrate: 5-year follow-up. Am J Stem Cell Res. 2018. https://doi.org/10.5923/j.ajscr.20180201.01.

  56. Haufe SMW, Mork AR. Intradiscal injection of hematopoietic stem cells in an attempt to rejuvenate the intervertebral discs. Stem Cells Dev. 2006;15(1):136–7. https://doi.org/10.1089/scd.2006.15.136.

    Article  PubMed  Google Scholar 

  57. Orozco L, Soler R, Morera C, Alberca M, Sanchez A, Garcia-Sancho J. Intervertebral disc repair by autologous mesenchymal bone marrow cells: a pilot study. Transplantation. 2011;92(7):822–8. https://doi.org/10.1097/TP.0b013e3182298a15.

    Article  PubMed  Google Scholar 

  58. Mochida J, Sakai D, Nakamura Y, Watanabe T, Yamamoto Y, Kato S. Intervertebral disc repair with activated nucleus pulposus cell transplantation: a three-year, prospective clinical study of its safety. Eur Cell Mater. 2015;29:202–12 discussion 212.

    Article  CAS  PubMed  Google Scholar 

  59. Elabd C, Centeno CJ, Schultz JR, Lutz G, Ichim T, Silva FJ. Intra-discal injection of autologous, hypoxic cultured bone marrow-derived mesenchymal stem cells in five patients with chronic lower back pain: a long-term safety and feasibility study. J Transl Med. 2016;14:253. https://doi.org/10.1186/s12967-016-1015-5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Piccirilli M, Delfinis CP, Santoro A, Salvati M. Mesenchymal stem cells in lumbar spine surgery: a single institution experience about red bone marrow and fat tissue derived MSCs. J Neurosurg Sci. 2017;61(2):124–33. https://doi.org/10.23736/S0390-5616.16.03266-X.

    Article  PubMed  Google Scholar 

  61. Lutz GE. Increased nuclear T2 signal intensity and improved function and pain in a patient one year after an intradiscal platelet-rich plasma injection. Pain Med. 2017;18(6):1197–9. https://doi.org/10.1093/pm/pnw299.

    Article  PubMed  Google Scholar 

  62. Kirchner F, Anitua E. Intradiscal and intra-articular facet infiltrations with plasma rich in growth factors reduce pain in patients with chronic low back pain. J Craniovert Jun Spine. 2016;7(4):250–6. https://doi.org/10.4103/0974-8237.193260.

    Article  Google Scholar 

  63. Sys J, Weyler J, Van Der Zijden T, Parizel P, Michielsen J. Platelet-rich plasma in mono-segmental posterior lumbar interbody fusion. Eur Spine J. 2011;20(10):1650–7. https://doi.org/10.1007/s00586-011-1897-0.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Peul WC, Van Den Hout WB, Brand R, Thomeer RTWM, Koes BW. Prolonged conservative care versus early surgery in patients with sciatica caused by lumbar disc herniation: two year results of a randomised controlled trial. BMJ. 2008;336:1355–8. https://doi.org/10.1136/bmj.a143.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Bush K, Cowan N, Katz DE, Gishen P. The natural history of sciatica associated with disc pathology: a prospective study with clinical and independent radiologic follow-up. Spine (Phila Pa 1976). 1992. https://doi.org/10.1097/00007632-199210000-00013.

  66. Guyer RD, Ohnmeiss DD. Lumbar discography. Spine J. 2003;3(3 Suppl):11S–27S.

    Article  PubMed  Google Scholar 

  67. Carragee EJ, Don AS, Hurwitz EL, Cuellar JM, Carrino J, Herzog R. 2009 ISSLS prize winner: does discography cause accelerated progression of degeneration changes in the lumbar disc: a ten-year matched cohort study. Spine (Phila Pa 1976). 2009. https://doi.org/10.1097/BRS.0b013e3181ab5432.

  68. McCormick Z, Lehman VT, Plasta-ras CT, Walega DR, Huddleston PM III, Kennedy DJ, et al. Low pressure lumbar provocation discography according tointernational association for the study of pain or spine interventionsociety standards does not cause accelerated progression of discdegeneration in symptomatic low back pain patients: a 7-year match. Spine J. 2018;18(8):S103.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zachary L. McCormick.

Ethics declarations

Conflict of Interest

Zachary McCormick serves on the Board of Directors of the Spine Intervention Society. Taylor Burnham, Aaron Conger, Quinn Tate, Daniel Cushman, Richard Kendall, and Byron Schneider declare no conflicts of interest relevant to this manuscript.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The original version of this article was revised: This article unfortunately contained a mistake in the authorgroup section. Author Byron Schneider's family name was incorrectly presented as “Schnieder”.

This article is part of the Topical Collection on Musculoskeletal Rehabilitation

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Burnham, T., Conger, A., Tate, Q. et al. The Effectiveness and Safety of Percutaneous Platelet-Rich Plasma and Bone Marrow Aspirate Concentrate for the Treatment of Suspected Discogenic Low Back Pain: a Comprehensive Review. Curr Phys Med Rehabil Rep 7, 372–384 (2019). https://doi.org/10.1007/s40141-019-00243-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40141-019-00243-6

Keywords

Navigation